Immutep Limited (IMMP:NASDAQ) soared at $3.68, representing a gain of 39.9%. On Wed 24 Mar 21, IMMP:NASDAQ hit a New 2-Week Low of $2.63. The stock appeared on our News Catalysts scanner on Wed 17 Mar 21 at 08:38 AM in the 'MISCELLANEOUS' category. From Wed 10 Mar 21, the stock recorded 60.00% Up Days and 54.55% Green Days
The stock spiked on Tue 12 Jan 21 at $3.63 with a volume of 1M+, and its share price has been moving sideways in recent weeks.
About Immutep Limited (IMMP:NASDAQ)
Immutep Ltd, formerly Prima Biomed Ltd is a biotechnology company. It is engaged in the development of immunotherapeutic products for cancer and autoimmune disease. Their operations are based in Australia and Europe.
Top 10 Gainers:
- GCAC (GCAC:NASDAQ), 100%
- ProQR Therapeutics N.V. (PRQR:NASDAQ), 62.32%
- Koss Corporation (KOSS:NASDAQ), 57.13%
- GameStop Corp. (GME:NYSE), 52.69%
- Immutep Limited (IMMP:NASDAQ), 39.92%
- Houston Wire & Cable Company (HWCC:NASDAQ), 37.63%
- Cellect Biotechnology Ltd. (APOP:NASDAQ), 36.68%
- KBS Fashion Group Limited (KBSF:NASDAQ), 31.3%
- Rubius Therapeutics, Inc. (RUBY:NASDAQ), 26.77%
- FreightCar America, Inc. (RAIL:NASDAQ), 23.39%